Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
about
Current use of medical eponyms--a need for global uniformity in scientific publicationsSynaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsTrisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomesModifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patientsIn vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha.Electrophysiology of reactive oxygen production in signaling endosomesA novel binding protein of single-minded 2: the mitotic arrest-deficient protein MAD2B.Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficitsRegional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's diseaseDysregulation of protein trafficking in neurodegeneration.Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.Autophagy failure in Alzheimer's disease--locating the primary defect.The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.Age-related neurodegeneration and memory loss in down syndrome.Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease.The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.Alzheimer's disease in a dish: promises and challenges of human stem cell models.Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down SyndromeEvidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-β protein precursor transgenic mice.Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Dynein dysfunction induces endocytic pathology accompanied by an increase in Rab GTPases: a potential mechanism underlying age-dependent endocytic dysfunctionImpairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.The early endosome: a busy sorting station for proteins at the crossroads.Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides.Frontotemporal dementia caused by CHMP2B mutations.Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer's disease pathology.Aging and intellectual disability: insights from mouse models of Down syndrome.Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
P2860
Q21261916-534FFA98-D36C-4C79-B54C-D548FF4F7AEEQ28077671-3BEC6641-D4BC-42EC-8878-9DBD892C19ABQ28118988-70DB4332-3270-4F65-BE3B-F97A1077FE6AQ30823831-81B5D521-0923-4AA7-8B3D-C97E0A574FCBQ33483363-73E0A35E-4B25-445A-85AA-DC2352D29099Q33639389-8235C3DE-1940-4745-94B4-503FD8EEBCC2Q33667620-872ED4C7-C597-4021-ADB5-FD227ECEADC7Q33741068-6BCD5C20-365A-4D29-A790-8E6700EF1CD8Q33858543-33393986-1FDF-424F-9560-93D8AC8F6487Q34290515-648C04E7-C5F9-4390-BB0B-99D48D0599CFQ34438646-73410911-7C7F-4800-B6F4-6B8FDF5FA6E2Q34543633-F6E370D7-6A93-4BA6-85A2-371C74B26CE5Q34545170-806D6156-853F-44AF-B9AF-EAECCB27310AQ34663489-5A38DDF0-F3A9-41AD-A580-8679D9F7CA30Q34987827-681767EB-A7E6-4336-9CA5-DC406F1A6660Q35126571-2A98AAAA-88DB-4705-9346-886058BAAF4CQ35186435-30FA980F-730A-47F6-A5C2-6CEC39568249Q35710041-5AC3E07C-7D86-42D5-8C84-510720B715A2Q35867093-23A4EE59-2CDB-47DE-9AA8-4A3FD0A3948BQ35894510-4C6A69C2-70E3-4A98-837D-79316349A424Q36119393-304C8214-FBB9-4DB4-A747-B86995951732Q36283888-9BAE3FD9-42AC-4BCE-AD68-821FF5F6A943Q36399166-9DCB764C-6589-4D9A-9851-22EBC61C5892Q36488014-4FEB2461-E109-4228-B9F6-B2E2D455D343Q36532851-3A032351-A765-4217-8633-C589A9DFEEA1Q36638747-6F662E6D-7E8B-43F0-9C27-E20946BDD5CCQ36681400-E7F3A9CF-3F97-43D0-854B-FF3A9A33F715Q36741304-D53C2819-CFD4-442A-8887-11C06725EC1AQ37279515-33915C25-870E-46E0-8FE2-6C43472B1F20Q37431510-7D7409AA-240B-42D4-9B70-DAB81BC80538Q37613081-B535E109-B764-40ED-A009-F4B130758513Q37635044-0F5C52D0-135C-4B30-9B0C-21220F5C33A9Q37677924-7E736EDB-00CA-4E2C-9CC4-FBC855C256E3Q37827517-DF982B07-D217-4C3B-8FA0-99349336F706Q37985671-55303FC8-32BC-470B-866E-B18600A47385Q38042636-F60EAB5B-24E4-4F68-9C4C-778B5C936E67Q38129324-17EE8D3A-906A-485F-AC44-5DFA31843D0FQ38195159-8965ABFE-B14F-45CE-BFB3-C6654A465065Q38603319-EB88D0DB-1CBB-4A20-BF60-394D1CCFA936Q38666481-58079B3C-27F8-44DC-88C1-0FC8A85C683E
P2860
Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Down syndrome fibroblast model ...... omotes late endocytic defects.
@ast
Down syndrome fibroblast model ...... omotes late endocytic defects.
@en
type
label
Down syndrome fibroblast model ...... omotes late endocytic defects.
@ast
Down syndrome fibroblast model ...... omotes late endocytic defects.
@en
prefLabel
Down syndrome fibroblast model ...... omotes late endocytic defects.
@ast
Down syndrome fibroblast model ...... omotes late endocytic defects.
@en
P2093
P2860
P1476
Down syndrome fibroblast model ...... omotes late endocytic defects.
@en
P2093
Anne Boyer Boiteau
Anne M Cataldo
Corrinne M Peterhoff
Jean Gruenberg
Kerry Mullaney
Linda C Hassinger
Rachael L Neve
Ralph A Nixon
Ying Jiang
P2860
P304
P356
10.2353/AJPATH.2008.071053
P407
P50
P577
2008-06-05T00:00:00Z